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We have shown previously that the length of cytoplasmic tails influences the selection of lipid substrates for palmitoylation
of influenza viral hemagglutinin esterase fusion (HEF) and hemagglutinin (HA) glycoproteins [Veit et al. (1996) Biochem. J. 318,
163–172; Reverey et al. (1996) J. Biol. Chem. 271, 23607–23610]. Using a series of new chimeric mutant proteins derived from
acylated influenza virus HA (subtype H7) and from nonacylated Sendai virus fusion protein (F, strain Z), we report here that
palmitoylation levels depend on the type of transmembrane or cytoplasmic domain, or both, present in the expression
products and that cysteine residues placed close to the cytoplasmic membrane border are not sufficient for acylation. By
inserting stretches of the HA transmembrane domain into a nonacylated mutant of Sendai F (FCys), we induce palmitoylation
after expression in CV.1 cells, and the level of fatty acid transfer increases with the length of the HA-derived insert. A
five-amino-acid shift of the HA transmembrane domain severely augments fatty acid transfer. Our data suggest that the
influenza virus HA contains complex conformational signals for palmitoylation that are mainly located within the transmem-
brane domain but also involve the C-tail region, whereas the extracellular (luminal) domain has only marginal influence on
palmitoylation. © 1998 Academic Press
INTRODUCTION
The influenza A virus contains two major envelope
spike glycoproteins: hemagglutinin (HA) and neuramini-
dase (NA). The HA, which is a typical type I membrane
glycoprotein with a long ectodomain, one transmem-
brane region, and a short cytoplasmic tail, possess re-
ceptor-binding and fusion activities and is the major viral
antigen. Besides its important role for virus infectivity
(Klenk and Rott, 1988), HA is a model system for glyco-
proteins in general because its structure, biosynthesis,
and posttranslational modifications have been charac-
terized in great detail (Wiley and Skehel, 1987; Bullough
et al., 1994; Lamb and Krug, 1996). HA is synthesized on
membrane-bound ribosomes and translocated into the
lumen of endoplasmic reticulum, where signal–peptide
cleavage, glycosylation, folding, disulfide-bond forma-
tion, and assembly into trimers occur (Gething et al.,
1986; Doms et al., 1993). During its intracellular transport
to the plasma membrane, HA undergoes extensive post-
translational modifications, including trimming of carbo-
hydrates, terminal glycosylation, and proteolytic cleav-
age into two subunits, which is necessary for the acti-
vation of fusion activity (Klenk and Garten, 1994).
Although the structural requirements for and biological
functions of these protein modifications have been ex-
tensively studied, little is known about another modifica-
tion of HA: the covalent attachment of fatty acids, which
is the subject of this report. A large number of viral as
well as cellular polypeptides have been found to be
modified by fatty acid binding (Towler et al., 1988;
Schmidt, 1989; Schlesinger et al., 1993), and two main
modes of acylation have been described: N-myristoyl-
ation and palmitoylation (S-acylation). N-Myristoylation is
a cotranslational modification catalyzed by N-myristoyl-
transferase, which modifies N-terminal glycine via an
amide bond in a stable linkage (Towler et al., 1988).
Palmitoylation reflects the post-translational addition of
long-chain fatty acids (mainly palmitic acid) into a thio-
ester linkage to particular cysteine residues (Schlesinger
et al., 1993).
The HA cytoplasmic tail contains 11 amino acids and
is highly conserved among the 14 HA subtypes (Nobu-
sawa et al., 1991). Two of these conserved residues are
cysteine, and a third highly conserved cysteine is located
within the transmembrane domain (Fig. 1). It has been
previously shown that these conserved cysteine resi-
dues are modified by covalently attached palmitate
through a thioester linkage (Naeve and Williams, 1990;
Veit et al., 1991a; Naim et al., 1992; Jin et al., 1996).
Possible involvement of palmitoylation into the fusion
process, virus infectivity, and virus assembly, as well as
into the virus replication, has been extensively studied in
the past years (Zurcher et al., 1994; Jin et al., 1994, 1996,
1997; Melikyan et al., 1997; Schroth-Diez et al., 1998). It
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was reported that palmitoylated cysteine residues of HA
(H7) are not crucial for HA-induced membrane fusion
activity in general (Philipp et al., 1995; Schroth-Diez et al.,
1998). On the other hand, palmitate covalently linked to
cysteine residues of the HA (H3) cytoplasmic tail could
be required for fusion pore flickering (Melikyan et al.,
1997). Zurcher et al. (1994) reported that cysteine resi-
dues in the cytoplasmic tail of HA (H3) are important for
infectious particle formation, and a study on the palmi-
toylation-deficient mutant of HA (H2) demonstrated the
requirement of acylation for the generation of virus that
can replicate in multiple cell types (Jin et al., 1996).
However, the molecular determinants for palmitoylation
of these particular cysteine residues have not yet been
characterized. Comparison of the palmitoylated cys-
teines of HA with those reported for other viral and
cellular membrane glycoproteins of both type I and II
reveals that most of the cysteine acylation sites are
located at the boundary between the transmembrane
region and the cytoplasmic tail (Fig. 1). Apparently, cys-
teine residues in positions up to ;17 amino acids from
the membrane border toward the cytoplasmic tail can
still serve as acylation sites (Kawate and Menon, 1994),
but fatty acid transfer does not occur if the distance
increases. Likewise, cysteine residues of the transmem-
brane domain are acylated only when they are located
close to the cytoplasmic border, because cysteines in
the middle or at the opposite end of the transmembrane
region are not acylated (underlined Cys residues in Fig.
1). However, the position of acylated cysteines varies
considerably in different acylproteins, and inspection of
the amino acids in the vicinity of the linkage site reveals
no obvious “consensus signal” for palmitoylation such as
has been established, for example, for N-myristoylation
(Towler et al., 1988). One could therefore postulate that a
transmembrane protein becomes acylated whenever
cysteine residues are adjacent to the boundary between
transmembrane region and cytoplasmic tail. However,
we could demonstrate recently that mutagenic insertion
of cysteine residues into this empirical “acylation region”
of a nonacylated fusion glycoprotein of Sendai virus is
not sufficient to cause the attachment of fatty acids
(Ponimaskin and Schmidt, 1995). Thus, additional struc-
tural features must be required for ester-type acylation of
transmembrane proteins, and these remain to be defined
in molecular terms.
In this study, the palmitoylated HA of influenza A virus
(subtype H7) and the nonacylated fusogenic spike pro-
tein of Sendai virus (termed F protein, strain Z) were
chosen as models to assay for the structural require-
ments for palmitoylation of viral membrane glycopro-
teins. We characterized mutants of F protein with cys-
FIG. 1. Palmitoylation sites in integral membrane proteins. Listed are the primary structures of acylated integral membrane proteins around the
cytoplasmic border region. Palmitoylated cysteine residues are clustered in a domain of the protein that is close to the inner leaflet of the plasma
membrane. Cysteine residues located in the middle or the outer part of the transmembrane region or cysteines of the cytoplasmic tail, located more
distantly to the membrane, are not palmitoylated. ,, Acylated cysteine residues; nonpalmitoylated cysteines are indicated in bold by underlining.
Amino acid sequences are given in single-letter codes as derived from published information as follows: Flu HA, influenza virus (subtype H7) HA
protein; VSV G, vesicular stomatitis virus G protein; Flu M2, influenza virus M2 protein; MuLV env, murine leukemia virus envelope protein; SFV E1,
Semliki forest virus E1 protein; p75LNTR, low affinity neurotropin receptor; FluC HEF, influenza C virus HEF protein; NDV F, Newcastle disease virus
F protein; SFV E2, Semliki forest virus F protein; p63, nonglycosylated integral membrane protein of 63 kDa; a2AR, a2A-adrenergic receptor; CD4,
human immunodeficiency virus receptor CD4.
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teine residues inserted into the potential acylation region
and a series of new chimeric proteins, where the trans-
membrane or cytoplasmic domains, or both, of palmitoy-
lated and nonpalmitoylated glycoproteins were recipro-
cally exchanged. Our results show that the transmem-
brane and cytoplasmic regions of HA contain structural
information critical for palmitoylation.
RESULTS
Expression and characterization of F-derived
chimerae
We previously expressed and characterized the
cloned F gene of Sendai virus in insect cells by using a
baculovirus system (Ponimaskin et al., 1994). Attachment
of fatty acids, which has been described for other
paramyxovirus F proteins, was not observed for the F
protein from Sendai virus particles (Veit et al., 1989) or for
the Sendai virus F protein from expression systems
(Ponimaskin et al., 1994; Ponimaskin and Schmidt, 1995).
Consistent with this, no cysteine residues are present in
the cytoplasmic or transmembrane part of this protein.
As shown in Figure 2B (lanes 2), we find that the inser-
tion of cysteine residues at different positions into the
cytoplasmic tail of F protein was not sufficient to cause
the attachment of fatty acids. To characterize additional
putative determinants required for efficient palmitoyl-
ation, we constructed and expressed two sets of chi-
meric proteins. The first group was created on the basis
of Sendai virus F protein in which the transmembrane or
FIG. 2. Schematic and analysis of the acylation efficiency of chimerae derived from F protein. (A) Solid bars indicate the F protein; dark gray bars
represent the fragment derived from HA protein. p, Relative position of cysteine acylation sites. The TMD is shown as a vertical box. Amino acid
sequences of TMD and cytoplasmic domains are shown in single-letter codes (for cytoplasmic domain of F only partially). In the chimera F/H9/FCys,
the cysteine of HA TMD had been previously replaced by isoleucine (designated H9). (Left) Chimerae designated by a three-letter code that defines
the origin of the external (left letter), the transmembrane (middle letter), and the cytoplasmic (right letter) domains. (Right) Mean 6 SE acylation
efficiencies from four independent experiments determined by densitometry and normalizing to one linkage site per polypeptide. HAwt was used as
a control, and the values obtained for HAwt were set to 100%. (B) CV.1 cells transfected with HAwt (H/H/H), Fcys (F/F/FCys), F/H/H, F/F/H, and F/H9/FCys
were labeled with Tran[35S]-label (left) or [3H]palmitic acid (right). Cell lysates were immunoprecipitated with antibodies directed against influenza
virus (HAwt and HA-derived chimerae) and with antibodies against Sendai virus (FCys and F-derived chimerae), respectively. Proteins were analysed
by SDS–PAGE (12% gel) and fluorography using exposure times of 1 day for methionine- or 6 days for palmitate-labeled samples. (Numbers on the
left) Positions of marker proteins (in kDa). (Right) Positions of uncleaved HA0 and its two subunits HA1 and HA2 in the gel.
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cytoplasmic region, or both, was replaced by the respec-
tive domain of HA protein (F-derived chimerae, Fig. 2A). A
three-letter code was used to designate the origin of the
three domains (extracellular, transmembrane, and cyto-
plasmic) in the various chimerae from either influenza
virus HA (H) or Sendai virus F protein (F).
All F-derived chimerae, along with HAwt (H/H/H) and
FCys (F/F/FCys), were transiently expressed in CV.1 cells with
a vaccinia virus expression system and labeled with either
Tran[35S]-label (ICN Radiochemicals) or [3H]palmitic acid
followed by immunoprecipitation, analysis by SDS–PAGE,
and fluorography. Results of the [35S]methionine/cysteine
labeling demonstrate that HA expressed in CV.1 is cleaved
into HA1 and HA2 subunits in the absence of other viral
gene products (Fig. 2B, first lane), as was observed previ-
ously with other expression systems (Veit et al., 1991a;
Ponimaskin and Schmidt, 1995; Philipp et al., 1995). No
such fragments are observed when the extracellular do-
main of the protein is derived from Sendai F (Fig. 2B, lanes
2–4). All the F-derived chimerae are expressed at levels
comparable to those of the HAwt control, which allows for
a quantitative comparison of palmitoylation levels in the
different products (see below).
A number of control experiments were done to verify the
normal processing and cellular transport of the chimerae:
treatment with the cross-linking reagent DSP and with dif-
ferent glycosidases (Endo H and PNGase F) demonstrated
that all F-derived chimerae were correctly oligomerized to
form tetramers like Fwt (Sechoy et al., 1987) and glycosy-
lated similarly to Fwt (data not shown). The correct subcel-
lular localization, as well as the level of surface expression
of F-derived chimerae, was confirmed by flow cytometry
analysis of transfected cells (Table 1).
Cells transfected with F-derived chimerae were tested
for [3H]palmitate incorporation in comparison with HAwt,
which was previously shown to be palmitoylated on three
conserved cysteine residues: one located in the transmem-
brane domain (TMD) and two located in the cytoplasmic
domain (Veit et al., 1991a; see also Fig. 1). As apparent from
Figure 2B (right) acylation levels reproducibly differed in the
different chimeric polypeptides. We estimated the relative
amounts of [3H]palmitate incorporated into each of these
constructs by densitometry of fluorograms. Because the
number of potentially acylated cysteine residues varied
between HAwt and the different chimerae [three cysteines
for HAwt (H/H/H), F/H/H, and two cysteines for F/F/H, F/H9/
FCys], palmitate incorporation was normalized by relating
densitometric values to one linkage site per polypeptide.
Incorporation of [3H]palmitate per linkage site into F/H/H,
F/F/H, and F/H9/FCys was 82.3 6 1%, 27 6 2.2%, and 34.2 6
1.2%, respectively (n 5 4). These results indicate that the
extracellular (luminal) domain of HA is not crucial for fatty
acid transfer to its own acylation sites, and thus the struc-
tural information for palmitoylation must be encoded in its
TM and cytoplasmic regions. The introduction of one or
both of these latter domains into the normally nonacylated
FCys protein is apparently sufficient for palmitoylation. It is of
particular interest that the new linkage site in the C-tail of
FCys becomes acylated when the TM region is derived from
HA but not when TMD is derived from Sendai F protein
(compare lanes F/F/FCys and F/H9/FCys in Fig. 2B).
Expression and characterization of HA-derived
chimerae
To characterize in more detail the putative protein
domain or domains that promote efficient acylation of
HA, we designed a series of HA-derived chimerae that
contained particular elements of Sendai F protein (Fig.
3A). These were transiently expressed along with HAwt
in CV.1 cells by the vaccinia virus system and analysed
as described above. As presented in Figure 3B, all HA-
derived chimerae, along with HAwt, showed incorpora-
tion of [3H]palmitate label into the small subunits and in
the uncleaved precursors, the intensity of which de-
pended on their domain structure. As long as at least one
of two domains (either TMD or C-tail) were derived from
HA, as in H/H9/FCys and H/F/H, expression products
were quite well labeled in contrast to the construct H/F/
FCys, which consistently showed only low levels of pal-
mitoylation. The relative palmitoylation values demon-
strate that incorporation of [3H]palmitic acid into H/H9/
FCys, H/F/H, and H/F/FCys was 49.2 6 5%, 36.9 6 4.3%,
and 16.3 6 3.3%, respectively (n 5 4).
The results of labeling experiments with [35S]methi-
onine/cysteine shown in Figure 3B (left) and those of
three additional independent experiments indicate that
TABLE 1
FACS Analysis of CV.1 Cells Transfected with F-Derived Chimeraea
Protein
Transfection
efficiency
(%)b
Mean
fluorescent
index (a.u.)c
Relative mean
fluorescent
index (%)d
F/F/F (Fwt) 43 588.21 100
F/F/FCys 34 548.03 93.2
F/F/H 33 433.23 73.6
F/H/H 37 437.14 74.3
F/H9/FCys 27 500.29 85.1
a The CV.1 cells cultured in 35-mm dishes were infected with vTF7-3
vaccinia virus and transfected with plasmids encoding the respective
protein as designated. After labeling with fluorescent antibodies the
cells were analyzed by FACS as previously described (Schrott-Diez et
al., 1998). About 50,000 cells were analyzed in each experiment.
b Transfection efficiency was determined by calculating all cells with
specific fluorescent activity above that of the control with respect of the
overall number of measured cells.
c The mean fluorescent index is a measure of the amount of protein
per expressing cells in its membrane. Therefore, it is a useful param-
eter for the relative surface density of the expressed protein.
d The relative mean fluorescent index was calculated with respect to
F/F/F (Fwt). It shows that F/F/FCys and all F-derived chimerae were
expressed at the cell surface with almost the same efficiency as Fwt.
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all HA-derived chimerae were as efficiently expressed as
HAwt, which excludes the possibility that these differ-
ences are caused by different expression levels. All
HA-derived chimeric proteins were cleaved into two sub-
units similar to HAwt (cleavage efficiencies for HAwt,
H/H9/FCys, H/F/H, and H/F/FCys of 60%, 48%, 48%, and
52%, respectively), and the analysis of oligomerization by
cross-linking experiments and of glycosylation revealed
that all constructs were oligomerized to form trimer like
HAwt, correctly glycosylated, and transported to the cell
surface, where they were detected by immunofluores-
cence and flow cytometry in parallel to the wild-type
controls (Schroth-Diez et al., 1998). All HA-derived chi-
merae had shown normal fusion activity in both extent
and kinetics in a previous study (Schroth-Diez et al.,
1998).
These data, together with the above results obtained
for the F-derived chimerae (Fig. 2), indicate that the
efficiency of palmitoylation is determined primarily by the
fine structure of the fatty acid linkage region as defined
mainly by both the TMD and the cytoplasmic tail.
Characterization of acylation determinants located
within the TMD of HA
The above results indicate that acylation of HA is to a
large part dependent on its TMD structure, so we were
interested in determining more closely the nature of this
signal. It is unlikely that the length of TMD is crucial for
acylation because both acylated and nonacylated pro-
teins show considerable differences in their TMD size
(E. Ponimaskin and M. F. G. Schmidt, unpublished obser-
vation; see also Fig. 1). Therefore, acylation must be
promoted by some specific amino acid sequence within
the TMD that confers the particular conformational prop-
erty preferred by acylating enzymes. A comparison of
FIG. 3. Schematic and analysis of acylation efficiency of chimerae derived from HA protein. (A) Wide boxes in gray indicate the HA protein; solid bars
represent fragments derived from F protein. p, Relative positions of cysteine residues in potential acylation region. The TMD is boxed vertically. Amino acid
sequences of TMD and cytoplasmic domain are shown in single-letter codes (for cytoplasmic domain of F only partially). In the chimera H/H9/FCys, the
cysteine of HA TMD was replaced by isoleucine (designated H9). (Left) Designates the constructs using the same codes as in Figure 2. (Numbers on the
right) Mean 6 SE acylation efficiency from four independent experiments. (B) CV.1 cells were transfected with HAwt (H/H/H) and with H/F/FCys, H/H9/FCys,
and H/F/H; labeled with either [35S]methionine/cysteine (left) or [3H]palmitate (right); and further analyzed as described for Figure 2B.
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helical wheel projections of the TMD sequences of the
acylated HA and the nonacylated Sendai F (Fig. 4B)
revealed that HA has a relatively nonhydrophobic face,
characterized by the two alanine and one glycine resi-
dues in positions 6, 9, and 20, which are flanked by three
of the total of four bulky phenylalanine residues in posi-
tions 5, 12, and 23. To test the significance of this feature
for acylation, we prepared expression plasmids encod-
ing HA with the TMD altered such that either all four
phenylalanine residues were replaced (Phe5, Phe7, and
Phe12 with Leu, Phe23 with Ile), or only Phe23 and Gly20
were changed by Ile and Val, respectively (Fig. 4A).
Calculation of the amount of [3H]palmitate incorporated
after expression of these mutants showed that the mu-
tation of all phenylalanine residues produced only a
small decrease in palmitoylation, whereas replacement
of Gly20 with Val resulted in a more pronounced effect
(20% decrease in palmitoylation).
To characterize further putative acylation determi-
nants located in the TMD of HA, we prepared a series
of derivatives of the F/F/FCys mutant in which the
cytoplasmic part of TMD was stepwisely replaced by
HA sequences with increasing size, starting from the
cytoplasmic border (Fig. 5A). The inserts were derived
from the respective region of the HA TMD in which the
only cysteine had previously been exchanged to iso-
leucine. Expression of these new TMD chimerae in
CV.1 cells in the presence of Tran[35S]-label revealed
that F/FH97/FCys, F/FH96/FCys, and F/FH94/FCys were as
efficiently translated and processed as the parent pro-
teins F/F/FCys and F/H9/FCys (Fig. 5B, left). However,
palmitoylation with [3H]palmitic acid of all these con-
structs occurred with markedly different efficiencies,
which increased with the size of the HA-derived insert.
Compared with HAwt, incorporation of [3H]palmitate
per linkage site into F/F/FCys, F/FH94/FCys, F/FH96/FCys,
and F/FH97/FCys was 0%, 4.5 6 1.4%, 10.3 6 1.9%, and
21.1 6 1.9%, respectively (n 5 3), when HAwt is taken
as 100%.
To test for the significance of the relative location of
any palmitoylation promoting regions within the TMD, we
shifted the TMD of HA in the construct H/H9/FCys toward
the N terminus by adding five amino acids derived from
the C-terminal end of the TMD of Sendai F protein (Fig.
6A, bottom). This new chimera was efficiently expressed
(Fig. 6), fully processed, and biological active as HAwt
and H/H9/FCys (not shown; compare with Schroth-Diez et
al., 1998). However, calculation of the acylation efficiency
of this construct revealed a dramatic decrease in the
level of palmitoylation from 49.2 6 5% for H/H9/FCys to
only 2.4 6 0.9% for H/H9F/FCys (n 5 3).
FIG. 4. Effect of point mutations within the HA TMD on acylation. (A) TMD sequences of Fwt and HAwt are shown in single-letter codes with
subscript numbers indicating the position of amino acids. The residues mutated in the TMD of HA are underlined. (Left) Final mutants. (Right) Mean 6
SE values from four independent experiments. Values for acylation efficiencies of the different mutants were determined as for Fig. 2A. (B) Helix wheel
plot of F and HA TMD. Note that the TMD of HA has a relatively nonhydrophobic face centred on the two alanine and one glycine residues at positions
9, 16, and 20, and this region is flanked by three phenylalanine residues at positions 5, 12, and 23 (boxed).
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DISCUSSION
From the primary structure of the many viral and cel-
lular membrane glycoproteins known to be palmitoy-
lated, no obvious consensus signal for acylation can be
deduced. The only common feature is that palmitoylated
cysteine residues are nearly exclusively located close to
the boundary between the transmembrane region and
the cytoplasmic tail (Fig. 1). This led researchers to
suggest that the sole presence of cysteine or cysteines
in this region might be the only requirement for efficient
palmitoylation. However, we found recently that cysteine
residues introduced into the nonacylated Sendai virus F
protein cytoplasmic tail close to the membrane-spanning
domain could not be palmitoylated at all (Ponimaskin and
Schmidt, 1995; see also second lanes in Fig. 2B). That
the presence of cysteine residues in the presumed link-
age region alone is not sufficient for acylation is also
supported by a report on the small hydrophobic (SH)
protein of human respiratory syncytial virus. The single
cysteine residue present in SH protein is located in the
cytoplasmic tail near the inner membrane face and
therefore should serve as an acceptor site for fatty acids,
as, for instance, in M2 protein of influenza A virus, which
has a similar structure (Veit et al., 1991b). However, SH
protein was not palmitoylated (Collins and Mottet, 1993).
Such observations led us and others to aim at locating
the additional structural features that are apparently re-
quired for efficient acylation in addition to cysteine res-
idues in the vicinity of the cytoplasmic border. Sequence
comparisons involving all known acylproteins has re-
vealed that no consensus sequence exists but that pos-
itively charged amino acids are often present in the
vicinity of acylated cysteines, which could potentially
influence the attachment of fatty acids (E. Ponimaskin
and M. F. G. Schmidt, unpublished observation). How-
ever, this possibility seems excluded because results
obtained in a series of experiments involving mutagen-
esis have demonstrated that cysteine residues remain
FIG. 5. Replacement of F sequences by homologous inserts derived from HA TMD induces palmitoylation. (A) Schematic of F/FH97/FCys,
F/FH96/FCys, and F/FH94/FCys chimerae. Solid bars indicate portions of F protein; gray bars represent inserted sequences from HA in which the
cysteine of its TMD had been replaced by isoleucine (designated H9). Amino acid sequences of TMD and cytoplasmic domain are shown in
single-letter codes (for cytoplasmic domain of F only partially). p, Relative position of cysteine acylation sites. The TMD is shown as a vertical box.
(Left) Designates the constructs. (Numbers on the right) Mean 6 SE values for acylation efficiencies (n 5 5). (B) CV.1 cells were transfected with
wild-type HA (H/H/H), as well as with the mutants shown in A. Immunoprecipitated F/H9/FCys, F/FH97/FCys, F/FH96/FCys, and F/FH94/FCys, labeled with
either [35S]methionine/cysteine (left) or [3H]palmitate (right) are shown after PAGE and fluorography as described in Figure 2B .
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efficiently palmitoylated independent of their immediate
amino acid neighbours (M. Veit, personal communica-
tion; Kennedy and Limbird, 1994; Schweizer et al., 1995).
Another type of potential acylation signal was recently
proposed by Schweizer et al. (1995), who investigated
the palmitoylation of type II membrane protein p63. The
authors proposed a model in which a six-amino-acid
spacing between the acylated cysteine residue and the
predicted transmembrane segment is critical for palmi-
toylation. Although apparently valid for p63, this motif
may not apply in a general sense because other than
p63, only vesicular stomatitis virus G protein (Rose et al.,
1984) and influenza virus HA (Veit et al., 1991a; Jin et al.,
1996) have the predicted six-amino-acid spacing, but
many other acylproteins are palmitoylated on cysteine
residues located within the TMD (Fig. 1).
The results presented in this report suggest that the
complete domain structure of HA is crucial for the at-
tachment of fatty acids. We find that replacement of the
C-tail of F/F/FCys by that of HA in the chimera F/F/H
reestablishes palmitoylation (Fig. 2), demonstrating that
the cytoplasmic tail of HA per se must provide particular
conformation that stimulates acylation. The TMD contrib-
utes to palmitoylation even more strongly because HA
TMD in the chimera F/H9/FCys yields a higher level of
fatty acids compared with F/F/H. The most pronounced
stimulation of palmitoylation occurs when both TMD and
the C-tail originated from HA (Figs. 2 and 5). The extra-
cellular (luminal) domains of the two proteins analysed
were found to have the weakest influence on palmitoyl-
ation, which can possibly be attributed to a marginal
stimulation of processing and surface expression of the
chimerae containing the HA luminal portion (not shown).
Our analysis of helical wheel plots revealed that one
face of the HA TMD helix is relatively polar, and the
results from mutagenesis experiments in Figures 4 and 5
indicate that the glycine residue centred on this side
apparently influences acylation. Interestingly, the ob-
FIG. 6. Insertion of pentapeptide derived from F into HA TMD inhibits acylation. (A) Schematic of H/H9/FCys and H/H9F/FCys chimerae. Solid bars
indicate F protein portions; gray bars designate parts of HA protein. Amino acid sequences of TMD are shown within the vertical box (single-letter
codes), which represents the TMD. Cysteine of HA TMD had been replaced by isoleucine (designated H9). Amino acid sequence of cytoplasmic
domain of FCys is shown in part (single-letter code). p, Relative position of cysteine acylation sites. (Left) Designates the constructs. (Numbers on the
right) Mean 6 SE values for acylation efficiencies (n 5 4). (B) CV.1 cells were transfected with wild-type HA (H/H/H), as well as with H/H9/FCys and
H/H9F/FCys, and labeled with either [
35S]methionine/cysteine (left) or [3H]palmitate (right). Proteins were immunoprecipitated from lysates and
analyzed as described in Figure 2B.
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served preponderance of glycine and other polar resi-
dues is quite common in the TMD of acylated proteins,
which contrasts markedly with the low frequencies of
such residues in the TMDs of nonacylated proteins
(E. Ponimaskin and M. F. G. Schmidt, unpublished obser-
vation). In addition to the polar residues themselves, the
precise position relative to the membrane border influ-
ences acylation efficiency because a fragmental exten-
sion of the TMD of HA by five amino acids drastically
reduces fatty acid transfer (Fig. 6). This suggests that the
complete conformational features in the inner TMD helix
are particularly important during enzymatic fatty acid
transfer, although the requirements for recognition are
evidently not stringent.
Attachment of fatty acids may modulate the orientation of
TMDs in the membrane (Joseph and Nagaraj, 1995; Koeppe
et al., 1996), and in the case of HA, such a new conforma-
tion could contribute to the interaction among the TM do-
mains of HA, NA, and M2 or to the repetitive opening and
closing of fusion pores (Melikyan et al., 1997).
The functional significance of TMD conformation in gen-
eral was recently discussed in a number of biological con-
texts (Ullrich and Schlessinger, 1990; Cosson et al., 1991;
Hennecke and Cosson, 1993; Kundu et al., 1996; MacKenzie
et al., 1997; Perlman et al., 1997). Our study emphasizes that
in viral spike proteins, too, transmembrane domains are not
just inert, helical membrane anchors but instead are re-
gions of some regulatory potential.
MATERIALS AND METHODS
Materials
[9,10-3H(N)]Palmitic acid (30–60 Ci/mmol) was pur-
chased from DuPont NEN. Tran[35S]-label (.1000 Ci/
mmol) was from ICN Radiochemicals. Enzymes used in
molecular cloning were obtained from New England Bio-
labs. Dulbecco’s modified Eagle’s medium (DMEM), tryp-
sin versene, and fetal calf serum (FCS) were purchased
from BioWhittaker (Belgium). Minimal essential medium
without L-methionine and L-glutamine, 2YT Medium, and
Lipofectin Reagent were from Life Technologies. Protein
A–Sepharose beads were from Pharmacia Biotech. Am-
pliTaq DNA Polymerase was from Perkin–Elmer. ExSite
polymerase chain reaction (PCR)-based Site-Directed
Mutagenesis Kit was purchased from Promega, and the
Sculptor in vitro mutagenesis system was from Amer-
sham. Cell culture dishes were purchased from Nunc.
Oligonucleotide primers used for sequencing and PCR
were synthesized by Pharmacia Biotech and GIBCO BRL.
Recombinant DNA procedures
All basic DNA procedures were as described by Sam-
brook et al. (1989).
For transient expression in CV.1 cells, the F wild-type (wt)
cDNA and HAwt (subtype H7) cDNA were subcloned into
the EcoRI site in the polylinker of the pTM1 vector (Moss et
al., 1990) and designated pTM/F and pTM/HA, respectively.
The construction of F mutants with cysteine residues
inserted into the cytoplasmic domain has been de-
scribed previously (Ponimaskin and Schmidt, 1995). The
F mutant with Ser530 and Gly534 replaced by cysteine
residues (FCys) was further used to create the chimeric
proteins. The construction of chimerae H/H9F/FCys, H/H9/
FCys, H/F/FCys, and H/F/H (Figs. 3A and 6A) was recently
described (Schroth-Diez et al., 1998). The chimerae
F/F/H, F/H/H, F/FH94/FCys, F/FH96/FCys, F/FH97/FCys, and
F/H9/FCys (Figs. 2A and 5A) were produced by standard
PCR protocols using the overlap extension technique
(Horton and Pease, 1991). The internal sense PCR prim-
ers were 59-ATC ATC GTG CTT AAG AAC GGA AAC ATG
CGG-39 (F/F/H) or 59-CTC AAG AGA GAC TGT GAT ACT
TTG GTT TAG C-39 (F/H/H and F/H9/FCys) or 59-CAT TAT
AGT GAT CTT CAT CAT AGT GTA TAG ACT C-39 (F/FH94/
FCys) or 59-GGT CAT TAT ATT GGT GTT CAT CAT AGT
GTA TAG-39 (F/FH96/FCys) or 59-GGT GGT CAT TGG CTT
GGT GTT CAT TAT AG-39 (F/FH97/FCys), and antisense
primers were or 59-GTT TCC GTT CTT AAG CAC GAT
GAT GAT CAC T-39 (F/F/H) or 59-CCA AAG TAT CAC AGT
CTC TCT TGA GTT GTA CC-39 (F/H/H and F/H9/FCys) or
59-CTA TGA TGA AGA TCA CTA TAA TGA CCA CC-39
(F/FH94/FCys) or 59-GAA CAC CAA TAT AAT GAC CAC
CAA TAT TAC G-39 (F/FH96/FCys) or 59-GAA CAC CAA
GCC AAT GAC CAC CAA TAT TAC G-39 (F/FH97/FCys). The
external PCR sense primers were 59-ATG ACA GCA TAT
ATC CAG AG-39 for all chimerae with the extracellular
part of F protein and 59-ATG AAC ACT CAA ATC CTG GTT
TTC-39 for all chimerae with the extracellular part of HA
protein. The external PCR antisense primer for all chi-
merae was 59-TTA GGC CTC TCG AGC TGC AG-39.
Plasmids with the point mutations within the HA TMD
(Fig. 4A) were constructed by Chameleon double-stranded,
site-directed mutagenesis kit (Stratagene) according to the
manufacturer’s protocol using oligonucleotides containing
mutations corresponding to each mutant.
All mutants and chimerae were verified by double-
stranded dideoxy DNA sequencing at the level of the
final plasmid.
Cell culture and vaccinia virus-based expression of
foreign genes
CV.1 cells were maintained as monolayer cultures in
DMEM supplemented with 5% FCS.
Transient expression of the F protein, F mutants, and HA,
as well as their chimerae, in CV.1 cells was performed as
described by Fuerst et al. (1986). Subconfluent monolayers
of cells grown on 35-mm-diameter plastic dishes were
infected at an m.o.i. of 10 pfu/cell with recombinant vaccinia
virus vTF7–3 (Fuerst et al., 1986), which expresses T7 RNA
polymerase, and the cells were incubated at 37°C for 60
min. The virus inoculum was removed, and cells were
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washed once with DMEM without FCS and transfected
with plasmid DNAs, using Lipofectin (Life Technologies) as
described by the manufacturer. About 3 mg of cDNA en-
coding F or HA glycoproteins or different chimerae was
used for transfection. At 4 h post-transfection, cells were
washed again with DMEM without FCS and further treated
for metabolic labeling.
Isotopic labeling of polypeptides,
immunoprecipitation, and SDS–PAGE
Before labeling with Tran[35S]-label, cells expressing
the recombinant glycoproteins were incubated in methi-
onine-deficient DMEM (DMEM/met2) for 30 min at 4 h
post-transfection and then labeled with 30 mCi of
Tran[35S]-label in 600 ml of DMEM/met2 for 3 h. For
labeling with [3H]palmitate, the cells were washed with
FCS-deficient DMEM at 4 h post-transfection and sub-
sequently labeled with 500 mCi of [3H]palmitate in 600 ml
of DMEM for 3 h at 37°C. Cells were then washed once
with ice-cold phosphate-buffered saline and lysed in
ice-cold RIPA buffer (0.15 M NaCl, 20 mM Tris–HCl, pH
7.4, containing 1% Triton X-100, 1% sodium deoxycholate,
0.1% SDS, 1 mM phenylmethylsulfonyl fluoride, and 10
mM iodoacetamide). Cell lysates (600 ml) were centri-
fuged at 14,000 g for 5 min, and the supernatants sub-
jected to immunoprecipitation overnight at 4°C. HA pro-
tein and chimerae containing the extracellular domain of
HA were immunoprecipitated with polyclonal antiserum
directed against influenza A virus (subtype H7); F protein,
F mutants, and chimerae containing the extracellular part
of F were precipitated with polyclonal antiserum directed
against Sendai virus (strain Z). Samples were gently
agitated for 2 h after the addition of 30 ml of Protein
A–Sepharose beads. The pellet was washed twice with
ice-cold RIPA buffer, and the immunocomplexes were
released from the beads by boiling for 1 min in electro-
phoresis sample buffer (62.5 mM Tris–HCl, pH 6.8, con-
taining 20% glycerol, 6% SDS, 10% b-mercaptoethanol,
and 0.002% Bromphenol blue). Radiolabeled polypep-
tides were analyzed by SDS–PAGE on 12% acrylamide
gels and visualized by fluorography using Kodak X-Omat
AR films.
Quantification
Quantification of fluorograms was carried out by
means of an Epson GT-9000 scanner and Biometra Scan-
Pack Version 3.0 Software. The amount of [3H]palmitate
incorporated was calculated relative to the expression of
the various proteins as indicated by its [35S]methionine/
cysteine labeling.
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